Synergy Research Group

What Synergy Research Group does

Synergy Research Group is a privately held Russian full-service Contract Research Organization (CRO), founded in 2002 and headquartered in Moscow, that provides end-to-end clinical trial management, regulatory support, and product registration services for pharmaceutical and medical device manufacturers. The company operates across Russia, Kazakhstan (representative office since 2007), and other EAEU and CIS markets, targeting both domestic and international sponsors. As of March 2025, Synergy employs 55 staff including 8 candidates of sciences and 28 medical/pharmaceutical-qualified personnel, and has completed 434 clinical and observational projects across more than 25 therapeutic areas for 108 clients from over 20 countries.

The company's core offering is a full-cycle clinical trial service — spanning Phase I–IV interventional trials, bioequivalence studies, observational studies, and Real-World Evidence — supported by modular services including feasibility assessment, project management, clinical and medical monitoring, data management (ALCOA+ principles, ICH GCP R3 compliant), biostatistics, medical writing, regulatory support, quality assurance, vendor management, and financial settlements with study sites. Its underlying technology includes Electronic Data Capture (EDC) systems, risk-based monitoring platforms, and a proprietary site/investigator database of over 1,000 clinical trial centers and 3,000+ physicians. Synergy is also a founding partner of the ACROSS Global Alliance, an international CRO network covering 90+ countries, and publishes the Orange Paper — free quarterly analytical reports on Russian and Kazakhstan clinical trials markets since 2007 and 2021 respectively.

Synergy generates revenue through project-based professional service fees on multi-year contracts, with custom pricing tied to trial scope, phase, therapeutic area, and geography. Distribution is conducted via direct enterprise sales with dedicated project managers, complemented by thought-leadership content marketing through the Orange Paper and LinkedIn. The company claims a 98% five-year client return rate and has processed over 7,800 site payments totaling more than 1 billion rubles since early 2022, indicating active operational throughput. No external funding rounds, institutional investors, or M&A activity are disclosed.

Name

Synergy Research Group

Legal name

Synergy Research Group

Website

https://srgcro.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

101–250 employees

Short description

Synergy Research Group is a Russian full-service Contract Research Organization (CRO), founded in 2002, providing end-to-end clinical trial management, regulatory support, and registration services for pharmaceutical and medical device companies across Russia, Kazakhstan, and EAEU/CIS markets.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Medical Writing & Regulatory Submission Support CROs (HLAGAAAG), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF)

Keywords

• Clinical trial services
• Contract research organization
• Regulatory affairs support
• Clinical data management
• Bioequivalence studies

Headquarters

HQ city

Moscow

HQ country

Russia

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Clinical Research Services: Full-service CRO providing comprehensive clinical trial services including project management, clinical monitoring, data management, biostatistics, regulatory support, medical writing, quality assurance, and registration services. Revenue is generated through project-based professional service fees for managing clinical trials from concept stage through post-marketing activities.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

Synergy Research Group is a Russian full-service Contract Research Organization (CRO) providing end-to-end clinical trial services for pharmaceutical sponsors and medical device manufacturers across Russia, Kazakhstan, and other EAEU and CIS countries. The company delivers Phase I–IV interventional trials, bioequivalence studies, observational studies, and Real-World Evidence studies, complemented by regulatory support, data management, biostatistics, medical writing, quality assurance, and registration services for Roszdravnadzor, EAEU, FDA, and EMA markets.

Product overview

Synergy Research Group is a Russian full-service Contract Research Organization (CRO) providing comprehensive, end-to-end clinical trial services covering the complete product lifecycle. The core offering is the Full-Service CRO encompassing Phase I–IV interventional trials, bioequivalence studies, observational clinical studies, and Real-World Evidence. This is supported by a modular service suite including Feasibility Assessment, Project Financial Planning and Budgeting, Medical Writing, Regulatory Support, Project Management, Clinical Monitoring, Medical Monitoring, Data Management, Biostatistics, Vendor Management, Quality Assurance, Financial Settlements with Study Sites, and Registration Services. The portfolio also includes the Orange Paper — a proprietary quarterly market intelligence publication on the Russian and Kazakhstan clinical trials markets published since 2007 — and participation in the ACROSS Global Alliance, an international CRO network spanning 90+ countries.

Differentiator

Problem solved

Functional benefit

Products and services

• Full-Service CRO (Contract Research Organization) End-to-end clinical trial management for pharmaceutical and medical device sponsors in Russia, Kazakhstan, and other EAEU and CIS countries, covering the full lifecycle from concept through post-marketing across Phase I–IV interventional trials, bioequivalence studies, observational studies, and Real-World Evidence.
• Feasibility Assessment Evaluation of the feasibility of running a clinical program or study in a specific geography, covering strategic, scientific, and operational recommendations and leveraging a proprietary database of more than 1,000 medical institutions and 3,000+ investigators.
• Project Management End-to-end clinical trial project management following PMBoK, Agile, and F.A.S.T. methodologies, spanning contract execution, document development, site and vendor selection, regulatory approval, logistics, monitoring, data management, statistical analysis, and final reporting.
• Clinical Monitoring On-site and remote monitoring visits, study site management, and centralized monitoring using a risk-based approach compliant with ICH GCP E6(R2) and FDA guidance.
• Medical Monitoring Medical oversight including safety evaluation, SAE/SAR review and reporting, patient eligibility assessment, and advisory support to investigators throughout the study.
• Data Management Clinical trial data management grounded in ALCOA+ principles and ICH GCP R3, including Data Management Plan development, Electronic Data Capture (EDC) validation, risk-based data management, and integration of data from multiple sources.
• Biostatistics Biostatistics support including hypothesis development, study design, sample size calculation, randomization method selection, statistical programming, statistical analysis plan, and final statistical report prepared in formats accepted by FDA and EMA regulators.
• Medical Writing Development, review, and finalization of clinical trial documentation including protocols, investigator brochures, informed consent forms, patient diaries, progress reports, and final clinical study reports.
• Regulatory Support Continuous regulatory support including assessment of regulatory risks, scientific consultations, dossier preparation, regulatory submissions, protocol amendments, import/export licenses, safety reporting, and ethics committee interactions across Russia, EAEU, CIS, FDA, and EMA jurisdictions.
• Registration of Medicines and Medical Devices Registration services for medicines, medical devices, and dietary supplements in line with Roszdravnadzor, EAEU, CIS, FDA, and EMA requirements, including gap analysis, dossier tailoring, import/export services, and GMP certification support.
• Quality Assurance Quality management system covering quality control, quality improvement, risk-based quality management, and full-cycle auditing of CROs, study sites, laboratories, and logistics companies — both on-site and remote — including CAPA plan development.
• Orange Paper Free quarterly analytical reports on the Russian and Kazakhstan clinical trials markets, published since 2007 for Russia and since 2021 for Kazakhstan, aggregating market data from credible open sources to support industry intelligence and thought leadership.

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• ACROSS Global AlliancecoreStrategic or Co-development PartnerSynergy Research Group is a founding partner of the international alliance of contract research organizations ACROSS Global Alliance. The alliance provides capabilities for conducting international-scale clinical trials across more than 90 countries worldwide, with 25+ partners, 8,000+ accredited medical institutions, 100+ successful projects, and coverage of 25+ therapeutic areas. This partnership enables Synergy to offer multinational clinical trial capabilities to its clients.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Charles River Laboratories: Global CRO with preclinical-to-clinical service breadth; relevant as a broader incumbent competing for integrated drug development programs where Synergy handles the EAEU clinical execution.
• ICON plc: Top-3 global CRO offering end-to-end clinical research services across all major geographies, including Russia/EAEU. Represents the scale ceiling Synergy competes against for large multinational sponsor programs.
• Medpace Holdings: Mid-size global CRO with selective therapeutic-area focus and growing Eastern European footprint. Comparable in service-model rigor and quality positioning to Synergy.
• Thermo Fisher Scientific (PPD): Global CRO incumbent operating through its PPD clinical research services business, with broad geographic reach and scale that competes for the largest EAEU-eligible sponsor programs.
• IQVIA: Largest global CRO/commercial services provider with extensive Russian operations and a named Synergy customer. Sets the competitive standard for full-service CRO delivery and pricing.
• Parexel International: Global full-service CRO with established Eastern European and Russian trial capabilities. Competes with Synergy for Phase II-IV work from Western pharma sponsors seeking EAEU coverage.
• Worldwide Clinical Trials: Global mid-size CRO that acquired ClinStar (a Russia-focused CRO) and operates one of the largest dedicated Russian/Eastern European clinical operations footprints. Competes with Synergy for regional and global sponsor awards.

Direct peers

• OCT Clinical Trials: Russia-based full-service CRO offering Phase I-IV clinical trial services across a similar therapeutic and geographic footprint as Synergy. Most direct head-to-head competitor for Russian and EAEU sponsor contracts.
• PSI CRO: Mid-size European-headquartered CRO with deep operations across Russia, Ukraine, and Central/Eastern Europe. Comparable in scale and therapeutic breadth to Synergy, and competes for the same regional multicenter trial work.
• Pharm-Olam International: Mid-size global CRO with a strong historical Eastern European and CIS operating footprint, competing for multinational Phase II-IV trials in the same geographies Synergy serves via the ACROSS Alliance.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/synergy-research-group-cro
• Facebookfacebook.com/SynergyCRO

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Synergy Research Group